qFIBS:自动定量评估非酒精性脂肪性肝炎纤维化、炎症、气球样变和脂肪变的技术
该研究基于219例来自亚洲和欧洲7个中心的NAFLD/NASH肝活检样本,利用二次谐波/双光子激发荧光成像开发并验证了qFIBS计算算法,可连续定量评估纤维化、炎症、肝细胞气球样变和脂肪变。qFIBS输出与NASH CRN评分各组分强相关(P<0.001),且具有高AUC值,能区分不同组织学分级/分期,但区分严重炎症和高气球样变分级时性能稍差。
要点
- qFIBS可自动定量NASH四大组织学特征,与NASH CRN评分强相关。
- qFIBS对脂肪变和纤维化的评估性能最佳。
- qFIBS有望提高NASH临床试验中肝活检评估的可重复性和标准化。
核心结论
- qFIBS是一种能准确量化NASH组织学评估关键组成部分的自动化工具,可能有助于NASH治疗临床试验所需的肝活检评估的可重复性和标准化。
研究设计与样本
- 研究从亚洲和欧洲7个中心获取219例NAFLD/NASH肝活检样本,通过二次谐波/双光子激发荧光成像采集图像,用于开发并验证qFIBS计算算法。
主要发现
- qFIBS自动分析输出与NASH CRN评分各相应组分强相关(P<0.001):qFibrosis r=0.776,qInflammation r=0.557,qBallooning r=0.533,qSteatosis r=0.802。
- qFIBS各组分AUC值高:qFibrosis 0.870-0.951(95%CI 0.787-1.000,P<0.001),qInflammation 0.820-0.838(95%CI 0.726-0.933,P<0.001),qBallooning 0.813-0.844(95%CI 0.708-0.957,P<0.001),qSteatosis 0.939-0.986(95%CI 0.867-1.000,P<0.001)。
- qFIBS能够区分不同的组织学疾病分级/分期。
- qFIBS在评估脂肪变程度和纤维化程度时性能最佳,但在区分严重炎症和更高气球样变分级时性能较差。
临床怎么用
- qFIBS可作为辅助工具用于NASH临床试验中肝活检的组织学评估,以提高可重复性和标准化。
局限性
- qFIBS在区分严重炎症和更高气球样变分级时性能较差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Nonalcoholic steatohepatitis (NASH) is a common cause of chronic liver disease. Clinical trials use the NASH Clinical Research Network (CRN) system for semiquantitative histological assessment of disease severity. Interobserver variability may hamper histological assessment, and diagnostic consensus is not always achieved. We evaluate a second harmonic generation/two-photon excitation fluorescence (SHG/TPEF) imaging-based tool to provide an automated quantitative assessment of histological features pertinent to NASH. APPROACH AND RESULTS: Images were acquired by SHG/TPEF from 219 nonalcoholic fatty liver disease (NAFLD)/NASH liver biopsy samples from seven centers in Asia and Europe. These were used to develop and validate qFIBS, a computational algorithm that quantifies key histological features of NASH. qFIBS was developed based on in silico analysis of selected signature parameters for four cardinal histopathological features, that is, fibrosis (qFibrosis), inflammation (qInflammation), hepatocyte ballooning (qBallooning), and steatosis (qSteatosis), treating each as a continuous rather than categorical variable. Automated qFIBS analysis outputs showed strong correlation with each respective component of the NASH CRN scoring (P < 0.001; qFibrosis [r = 0.776], qInflammation [r = 0.557], qBallooning [r = 0.533], and qSteatosis [r = 0.802]) and high area under the receiver operating characteristic curve values (qFibrosis [0.870-0.951; 95% confidence interval {CI}, 0.787-1.000; P < 0.001], qInflammation [0.820-0.838; 95% CI, 0.726-0.933; P < 0.001), qBallooning [0.813-0.844; 95% CI, 0.708-0.957; P < 0.001], and qSteatosis [0.939-0.986; 95% CI, 0.867-1.000; P < 0.001]) and was able to distinguish differing grades/stages of histological disease. Performance of qFIBS was best when assessing degree of steatosis and fibrosis, but performed less well when distinguishing severe inflammation and higher ballooning grades. CONCLUSIONS: qFIBS is an automated tool that accurately quantifies the critical components of NASH histological assessment. It offers a tool that could potentially aid reproducibility and standardization of liver biopsy assessments required for NASH therapeutic clinical trials.
引用
- Liu F, Goh GB, Tiniakos D, et al. qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis. Hepatology. 2020. PMID: 31600834. doi:10.1002/hep.30986
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。